Please use this identifier to cite or link to this item:
Título : Melatonin agonists for treatment of sleep and depressive disorders
Autor : Srinivasan, Venkataramanujan 
Cardinali, Daniel Pedro 
Pandi Perumal, Seithikurippu R. 
Brown, Gregory M. 
Fecha de publicación : 2011
Editorial : GESDAV Foundation
Cita : Srinivasan, V., et al. Melatonin agonists for treatment of sleep and depressive disorders [en línea]. Journal of experimental and integrative medicine. 2011, 1 (3). doi:10.5455/ Disponible en
Resumen : Abstract: Melatonin the hormone secreted by the pineal gland has been effective in improving sleep both in normal sleepers and insomniacs and has been used successfully in treating sleep and circadian rhythm sleep disorders. The lack of consistency in the reports published by the authors is attributed to the differential bioavailabilty and short half-life of melatonin. Sleep disturbances are also prominent features of depressive disorders. To overcome this problem, melatonergic agonists with sleep promoting properties have been introduced in clinical practice. Ramelteon, the MT1/ MT2 melatonergic agonist, has been used in a large number of clinical trials involving chronic insomniacs and has been found effective in improving the total sleep time and sleep efficiency of insomniacs and has not manifested serious adverse effects. The development of another MT1/MT2 melatonergic agonist agomelatine with antagonsim to 5-HT2c serotonin receptors has been found useful not only in treating sleep problems of patients but also as a first line antidepressant with earlier onset of actions in patients with major depressive disorder. An agonist for MT3 melatonin receptor has also been found effective in animal models of depression.
ISSN : 1309-4572 (impreso)
2146-3298 (online)
Disciplina: MEDICINA
DOI: 10.5455/
Derechos: Acceso Abierto
Appears in Collections:Artículos

Files in This Item:
File Description SizeFormat
melatonin-agonists-for-treatment-sleep.pdf327,59 kBAdobe PDFThumbnail
Show full item record

Page view(s)

checked on Aug 11, 2022


checked on Aug 11, 2022

Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons